Budi Oetomo Narendra 
Billy Candra 
Lina carolina 
Hendra Lukman 
Gilang Cahya Sling Therapeutics Secures $123 Million Series C to Advance Oral Thyroid Eye Disease Drug into Global Phase 3 Testing
admin Ann Arbor, Michigan – Biotechnology innovator Sling Therapeutics announced on Wednesday the successful closure of...
The Pervasive Impact of Fear of Cancer Recurrence on Breast Cancer Survivors’ Lives Unveiled in New Landmark Study
Breast cancer is the world’s most prevalent cancer, affecting millions globally each year. While advancements...
Second-hand Smoke During Childhood Leaves Lasting Epigenetic Scars Linked to Future Disease Risk
Children exposed to second-hand smoke in their homes are significantly more likely to exhibit alterations...
Stanford Medicine Scientists Unveil Groundbreaking Strategy to Erase Type 1 Diabetes in Mice
Stanford Medicine scientists have achieved a significant breakthrough in the fight against Type 1 diabetes,...
Japanese Researchers Develop Novel siRNA Modification to Enhance Genetic Therapy Safety
A groundbreaking chemical modification of small interfering RNA (siRNA) by researchers at Nagoya University in...
Liquid Biopsy Breakthrough: Blood Test Accurately Predicts Skin Cancer Recurrence
Nana O A groundbreaking study led by researchers at NYU Langone Health and its Perlmutter Cancer Center...
Spring Into Action: National Sports-Based Fundraising Campaigns Accelerate Childhood Cancer Research Initiatives
As the spring 2025 season commences, a series of high-profile athletic partnerships and community-driven events...
Nicotinamide Study Shows Significant Reduction in Skin Cancer Risk for Veterans Starting Early Treatment
Suherman Candra Maholtra A comprehensive study conducted by researchers at Vanderbilt University Medical Center and the Department of...
Leipzig University Uncovers GPR133 as Novel Therapeutic Target for Osteoporosis, Offering Dual Benefits for Bone and Muscle Health
Osteoporosis, a debilitating condition characterized by weakened bones and an elevated risk of fractures, represents...
Novartis Secures Global Rights to Sironax Brain Delivery Platform in $125 Million Upfront Deal, Bolstering Neuroscience Pipeline
Basel, Switzerland, and Boston, MA – In a significant move poised to reshape the landscape...
